Drug interactions that you need to know!

被引:2
作者
Voigt, N. [1 ]
Ort, K. [2 ]
Sossalla, S. [3 ]
机构
[1] Univ Med Gottingen, Mol Pharmakol, Gottingen, Germany
[2] Univ Med Gottingen, Thorax Herz & Gefasschirurg, Gottingen, Germany
[3] Univ Klinikum Regensburg, Expt & Intervent Kardiol, Regensburg, Germany
来源
PNEUMOLOGIE | 2019年 / 73卷 / 05期
关键词
Arzneimittelinteraktionen; Cytochrom P450; Polypharmazie; Pharmakokinetik; Pharmakodynamik; drug-drug interactions; cytochrome P450; polypharmacy; pharmacokinetics; pharmacodynamics; SEROTONIN REUPTAKE INHIBITORS; MECHANISMS; RISK;
D O I
10.1055/a-0863-6242
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Arzneimittelinteraktionen (AMI) sind ein haufig unterschatztes Problem der modernen Medizin. Die Zahl alterer, multimorbider Patienten, die mehrere Wirkstoffe gleichzeitig einnehmen, nimmt stetig zu - der damit verbundene exponentielle Anstieg moglicher AMI ist fast unuberschaubar. Diese ubersicht stellt haufige, relevante AMI anhand von Beispielen dar und zeigt Strategien auf, wie sie in der Praxis fruhzeitig erkannt und vermieden werden konnen. Abstract Drug-drug interactions (DDI) represent a significant problem in modern medicine. The number of patients with multi-morbidity, who take multiple drugs, is constantly increasing (polypharmacy). The related exponential increase in potential DDI is almost incomprehensible. In this article, we review pharmacodynamic DDI and provide clinically relevant examples. In addition, we extensively review pharmakokinetic DDI (e.g. through the cytochrome P450-system or p-glycoproteins) that can modify the plasma concentration of many compounds, thereby also increasing the likelihood of unwanted side effects. Finally we provide tools, which may help clinicians in their daily practice to identify and avoid potential DDI. In the context of an ageing society receiving polypharmacy, a better awareness of DDI and of strategies to prevent them is expected to reduce mortality and morbidity.
引用
收藏
页码:306 / 318
页数:13
相关论文
共 25 条
[11]   Which Drug Interactions the General Practioner Should Know [J].
Haffner S. ;
Thürmann P.A. .
Medizinische Klinik, 2004, 99 (3) :137-147
[12]   The interaction between St John's wort and an oral contraceptive [J].
Hall, SD ;
Wang, ZQ ;
Huang, SM ;
Hamman, MA ;
Vasavada, N ;
Adigun, AQ ;
Hilligoss, JK ;
Miller, M ;
Gorski, JC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (06) :525-535
[13]   Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation [J].
Heidbuchel, Hein ;
Verhamme, Peter ;
Alings, Marco ;
Antz, Matthias ;
Diener, Hans-Christoph ;
Hacke, Werner ;
Oldgren, Jonas ;
Sinnaeve, Peter ;
Camm, A. John ;
Kirchhof, Paulus .
EUROPACE, 2015, 17 (10) :1467-1507
[14]   Cardiac safety assays [J].
Heijman, Jordi ;
Voigt, Niels ;
Carlsson, Leif G. ;
Dobrev, Dobromir .
CURRENT OPINION IN PHARMACOLOGY, 2014, 15 :16-21
[15]   High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs - pharmacological mechanisms and clinical relevance [J].
Hohlfeld, Thomas ;
Saxena, Aaruni ;
Schroer, Karsten .
THROMBOSIS AND HAEMOSTASIS, 2013, 109 (05) :825-833
[16]   Cardiovascular Safety of Phosphodiesterase Type 5 Inhibitors After Nearly 2 Decades on the Market [J].
Kloner, Robert A. ;
Goldstein, Irwin ;
Kirby, Michael G. ;
Parker, John D. ;
Sadovsky, Richard .
SEXUAL MEDICINE REVIEWS, 2018, 6 (04) :583-594
[17]   Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4 [J].
Li, Daniel Q. ;
Kim, Richard ;
McArthur, Eric ;
Fleet, Jamie L. ;
Bailey, David G. ;
Juurlink, David ;
Shariff, Salimah Z. ;
Gomes, Tara ;
Mamdani, Muhammad ;
Gandhi, Sonja ;
Dixon, Stephanie ;
Garg, Amit X. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2015, 187 (03) :174-180
[18]   Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs [J].
Loke, Y. K. ;
Trivedi, A. N. ;
Singh, S. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (01) :31-40
[19]   Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature [J].
Meid, Andreas D. ;
Bighelli, Irene ;
Maechler, Sarah ;
Mikus, Gerd ;
Carra, Giuseppe ;
Castellazzi, Mariasole ;
Lucii, Claudio ;
Martinotti, Giovanni ;
Nose, Michela ;
Ostuzzi, Giovanni ;
Barbui, Corrado ;
Haefeli, Walter E. .
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2017, 7 (12) :251-264
[20]   Investigating the Additive Interaction of QT- Prolonging Drugs in Older People Using Claims Data [J].
Meid, Andreas D. ;
von Medem, Anna ;
Heider, Dirk ;
Adler, Juergen-Bernhard ;
Guenster, Christian ;
Seidling, Hanna M. ;
Quinzler, Renate ;
Koenig, Hans-Helmut ;
Haefeli, Walter E. .
DRUG SAFETY, 2017, 40 (02) :133-144